Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Chu

Showing results (111-120 of 230) with videos related to

Pageof 23
Sort By:
Alimentary Pharmacology & Therapeutics|April 14, 2016
Clinical outcomes after spontaneous and nucleos(t)ide analogue-treated HBsAg seroclearance in chronic HBV infectionY C Chen, W J Jeng, R N Chien, et al.
Hepatology (Baltimore, Md.)|January 1, 1987
Changes of serum hepatitis B virus DNA in two types of clinical events preceding spontaneous hepatitis B e antigen seroconversion in chronic type B hepatitisY F Liaw, C C Pao, C M Chu, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1985
Serodiagnosis of acute B hepatitis: comparison between a competitive binding radioimmunoassay and an enzyme linked immunosorbent assay for IgM antibody to hepatitis B core antigenY F Liaw, C M Chu, L H Lin, et al.
Liver|June 1, 1989
Natural course of patients with chronic type B hepatitis following acute hepatitis delta virus superinfectionH H Lin, Y F Liaw, T J Chen, et al.
Hepatology (Baltimore, Md.)|August 29, 2000
Prednisolone priming enhances Th1 response and efficacy of subsequent lamivudine therapy in patients with chronic hepatitis BY F Liaw, S L Tsai, R N Chien, et al.
Oncogene|November 15, 2000
Identification and characterization of a prevalent hepatitis B virus X protein mutant in Taiwanese patients with hepatocellular carcinomaC T Yeh, C H Shen, D I Tai, et al.
Journal of Virology|October 17, 2001
Identification of a hepatic factor capable of supporting hepatitis C virus replication in a nonpermissive cell lineC T Yeh, H Y Lai, T C Chen, et al.
Hepatology (Baltimore, Md.)|March 3, 1999
Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infectionS M Lin, I S Sheen, R N Chien, et al.
Journal of Hepatology|January 1, 1991
Why most patients with hepatitis delta virus infection are seronegative for hepatitis B e antigen. A prospective controlled studyY F Liaw, J T Dong, K W Chiu, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|October 19, 2016
Diagnostic value of apoptosis biomarkers in severe sepsis-A pilot studyC-M Chu, K-C Kao, S-H Huang, et al.
Pageof 23

Showing results (111-120 of 230) with videos related to

Sort By:
Pageof 23
Alimentary Pharmacology & Therapeutics|April 14, 2016
Clinical outcomes after spontaneous and nucleos(t)ide analogue-treated HBsAg seroclearance in chronic HBV infectionY C Chen, W J Jeng, R N Chien, et al.
Hepatology (Baltimore, Md.)|January 1, 1987
Changes of serum hepatitis B virus DNA in two types of clinical events preceding spontaneous hepatitis B e antigen seroconversion in chronic type B hepatitisY F Liaw, C C Pao, C M Chu, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1985
Serodiagnosis of acute B hepatitis: comparison between a competitive binding radioimmunoassay and an enzyme linked immunosorbent assay for IgM antibody to hepatitis B core antigenY F Liaw, C M Chu, L H Lin, et al.
Liver|June 1, 1989
Natural course of patients with chronic type B hepatitis following acute hepatitis delta virus superinfectionH H Lin, Y F Liaw, T J Chen, et al.
Hepatology (Baltimore, Md.)|August 29, 2000
Prednisolone priming enhances Th1 response and efficacy of subsequent lamivudine therapy in patients with chronic hepatitis BY F Liaw, S L Tsai, R N Chien, et al.
Oncogene|November 15, 2000
Identification and characterization of a prevalent hepatitis B virus X protein mutant in Taiwanese patients with hepatocellular carcinomaC T Yeh, C H Shen, D I Tai, et al.
Journal of Virology|October 17, 2001
Identification of a hepatic factor capable of supporting hepatitis C virus replication in a nonpermissive cell lineC T Yeh, H Y Lai, T C Chen, et al.
Hepatology (Baltimore, Md.)|March 3, 1999
Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infectionS M Lin, I S Sheen, R N Chien, et al.
Journal of Hepatology|January 1, 1991
Why most patients with hepatitis delta virus infection are seronegative for hepatitis B e antigen. A prospective controlled studyY F Liaw, J T Dong, K W Chiu, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|October 19, 2016
Diagnostic value of apoptosis biomarkers in severe sepsis-A pilot studyC-M Chu, K-C Kao, S-H Huang, et al.
Pageof 23